Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece

Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece

Saved in:
Bibliographic Details
Published in:Value in health Vol. 17; no. 7; p. A632
Main Authors: Fragoulakis, V, Papakostas, P, Pentheroudakis, G, Dervenis, C, Maniadakis, N
Format: Journal Article
Language:English
Published: United States 01-11-2014
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2014.08.2263